The prognostic role of lymphocyte count for treatment response in immune checkpoint inhibitor therapy

被引：0
|
作者：
Conroy, M. [1 ]
O'Sullivan, H. [2 ]
Collins, D. [1 ]
Bambury, R. [1 ]
Power, D. G. [1 ]
Grossman, S. [3 ]
O'Reilly, S. [1 ]
机构：
[1] Cork Univ Hosp, Dept Med Oncol, Cork, Ireland
[2] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Dept Med Oncol, Dublin, Ireland
[3] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Med Oncol, Baltimore, MD USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.244
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
123P
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [1] The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy
    Dean, Nathan J.
    d'Arienzo, Paolo D.
    Ibraheim, Hajir
    Lee, Karla A.
    Olsson-Brown, Anna C.
    Pinato, David J.
    Powell, Nicholas
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2024, 72
  • [2] DECREASE IN ABSOLUTE LYMPHOCYTE COUNT IN IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS
    Drobni, Zsofia
    Zafar, Amna
    Zlotoff, Daniel
    Zubiri, Leyre
    Alvi, Raza
    Zhang, Lili
    Rokicki, Adam
    Nohria, Anju
    Villani, Alexandra-Chloe
    Groarke, John
    Sullivan, Ryan J.
    Reynolds, Kerry L.
    Neilan, Tom
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 888 - 888
  • [3] The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer
    Naqash, Abdul Rafeh
    Kihn-Alarcon, Alba J.
    Stavraka, Chara
    Kerrigan, Kathleen
    Vareki, Saman Maleki
    Pinato, David James
    Puri, Sonam
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [4] An Algorithm as a Biomarker for Response to Immune Checkpoint Inhibitor Therapy
    Rimm, David L.
    JAMA ONCOLOGY, 2023, 9 (01) : 60 - 61
  • [5] The role of gut microbiota in immune checkpoint inhibitor therapy
    Yi, Ming
    Qin, Shuang
    Chu, Qian
    Wu, Kongming
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (06) : 481 - 483
  • [6] Prognostic Value of Neutrophil to Lymphocyte Ratio in NSCLC Patients Receiving First Line Immune Checkpoint Inhibitor Therapy
    Surya, N.
    Li, M.
    Zhao, S.
    Wei, L.
    Patel, S.
    Lopez, G.
    Johns, A.
    Grogan, M.
    Bertino, E.
    He, K.
    Shields, P.
    Carbone, D.
    Otterson, G.
    Presley, C.
    Owen, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S578 - S579
  • [7] Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis
    Drobni, Zsofia D.
    Zafar, Amna
    Zubiri, Leyre
    Zlotoff, Daniel A.
    Alvi, Raza M.
    Lee, Charlotte
    Hartmann, Sarah
    Gilman, Hannah K.
    Villani, Alexandra-Chloe
    Nohria, Anju
    Groarke, John D.
    Sullivan, Ryan J.
    Reynolds, Kerry L.
    Zhang, Lili
    Neilan, Tomas G.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (23):
  • [8] Neutrophil-to-lymphocyte ratio as a predictor of immune checkpoint inhibitor therapy response in advanced bladder cancer
    Nair, Monica
    Dawsey, Scott
    Pramod, Nikhil
    Clemenceau, Jean Rene
    Gilligan, Timothy D.
    Ornstein, Moshe Chaim
    Wee, Christopher Eing
    Nizam, Amanda
    Almassi, Nima
    Weight, Christopher J.
    Gray, Michi
    Echle, Jessica
    Ciezki, Jay P.
    Stephans, Kevin L.
    Tendulkar, Rahul D.
    Scott, Jacob
    Gupta, Shilpa
    Mian, Omar Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors
    M. R. Conroy
    H. O’Sullivan
    D. C. Collins
    R. M. Bambury
    D. Power
    S. Grossman
    S. O’Reilly
    BJC Reports, 2 (1):
  • [10] Role of MS Disease Modifying Therapy in Concomitant Oncologic Immune Checkpoint Inhibitor Treatment
    Siddiqui, A.
    Hersh, C. M.
    Hua, L. H.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 214 - 215
12345